Why AD still needs better solutions? Role of IL-13 in AD & itch, what makes lebrikizumab different?

Overview

eP2P on Atopic dermatitis disease area to be presented by: .
Dr. Ruaa Alharthi 
Dr. Dana Alessa 
Dr. Yousef Ben Amer 
Dr. Fares Alkhayal 
The whole session will be Chaired by Prof. Issam Hamada 

This Activity for

• Resident / Fellow
• Physician
• Pharmacy
• Clinical Pharmacy

What I will learn?

1 – Understand the heterogeneity of Atopic Dermatitis and Identify the Right Treatment for Right Patient
2 – Review the clinical benefits of lebrikizumab presenting clinical cases on AD

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
Why AD still needs better solutions Certificate	Certificate	Free